The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sofosbuvir Tablets Market Research Report 2025
Synopsis
Global Sofosbuvir Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sofosbuvir Tablets market research.
Key manufacturers engaged in the Sofosbuvir Tablets industry include Gilead Sciences, Inc., Shandong Shibo Jindu Pharmaceutical Co., Ltd., CTTQ, Sihuan Pharmaceutical Holdings Group Ltd., Cspc Ouyi Pharmaceutical Co., Ltd., Beijing Kawin Technology Share-Holding Co., Ltd., DM Pharma, Wellona Pharma and Mylan Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sofosbuvir Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sofosbuvir Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gilead Sciences, Inc.
Shandong Shibo Jindu Pharmaceutical Co., Ltd.
CTTQ
Sihuan Pharmaceutical Holdings Group Ltd.
Cspc Ouyi Pharmaceutical Co., Ltd.
Beijing Kawin Technology Share-Holding Co., Ltd.
DM Pharma
Wellona Pharma
Mylan Laboratories
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sofosbuvir Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Sofosbuvir Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sofosbuvir Tablets market research.
Key manufacturers engaged in the Sofosbuvir Tablets industry include Gilead Sciences, Inc., Shandong Shibo Jindu Pharmaceutical Co., Ltd., CTTQ, Sihuan Pharmaceutical Holdings Group Ltd., Cspc Ouyi Pharmaceutical Co., Ltd., Beijing Kawin Technology Share-Holding Co., Ltd., DM Pharma, Wellona Pharma and Mylan Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sofosbuvir Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sofosbuvir Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gilead Sciences, Inc.
Shandong Shibo Jindu Pharmaceutical Co., Ltd.
CTTQ
Sihuan Pharmaceutical Holdings Group Ltd.
Cspc Ouyi Pharmaceutical Co., Ltd.
Beijing Kawin Technology Share-Holding Co., Ltd.
DM Pharma
Wellona Pharma
Mylan Laboratories
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sofosbuvir Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Sofosbuvir Tablets Market Overview
1.1 Product Overview and Scope of Sofosbuvir Tablets
1.2 Sofosbuvir Tablets Segment by Type
1.2.1 Global Sofosbuvir Tablets Market Value Comparison by Type (2023-2029)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Sofosbuvir Tablets Segment by Application
1.3.1 Global Sofosbuvir Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Sofosbuvir Tablets Market Size Estimates and Forecasts
1.4.1 Global Sofosbuvir Tablets Revenue 2018-2029
1.4.2 Global Sofosbuvir Tablets Sales 2018-2029
1.4.3 Global Sofosbuvir Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sofosbuvir Tablets Market Competition by Manufacturers
2.1 Global Sofosbuvir Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sofosbuvir Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sofosbuvir Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Sofosbuvir Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sofosbuvir Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sofosbuvir Tablets, Product Type & Application
2.7 Sofosbuvir Tablets Market Competitive Situation and Trends
2.7.1 Sofosbuvir Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sofosbuvir Tablets Players Market Share by Revenue
2.7.3 Global Sofosbuvir Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sofosbuvir Tablets Retrospective Market Scenario by Region
3.1 Global Sofosbuvir Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sofosbuvir Tablets Global Sofosbuvir Tablets Sales by Region: 2018-2029
3.2.1 Global Sofosbuvir Tablets Sales by Region: 2018-2023
3.2.2 Global Sofosbuvir Tablets Sales by Region: 2024-2029
3.3 Global Sofosbuvir Tablets Global Sofosbuvir Tablets Revenue by Region: 2018-2029
3.3.1 Global Sofosbuvir Tablets Revenue by Region: 2018-2023
3.3.2 Global Sofosbuvir Tablets Revenue by Region: 2024-2029
3.4 North America Sofosbuvir Tablets Market Facts & Figures by Country
3.4.1 North America Sofosbuvir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sofosbuvir Tablets Sales by Country (2018-2029)
3.4.3 North America Sofosbuvir Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sofosbuvir Tablets Market Facts & Figures by Country
3.5.1 Europe Sofosbuvir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sofosbuvir Tablets Sales by Country (2018-2029)
3.5.3 Europe Sofosbuvir Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sofosbuvir Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Sofosbuvir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sofosbuvir Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Sofosbuvir Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sofosbuvir Tablets Market Facts & Figures by Country
3.7.1 Latin America Sofosbuvir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sofosbuvir Tablets Sales by Country (2018-2029)
3.7.3 Latin America Sofosbuvir Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sofosbuvir Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Sofosbuvir Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sofosbuvir Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sofosbuvir Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sofosbuvir Tablets Sales by Type (2018-2029)
4.1.1 Global Sofosbuvir Tablets Sales by Type (2018-2023)
4.1.2 Global Sofosbuvir Tablets Sales by Type (2024-2029)
4.1.3 Global Sofosbuvir Tablets Sales Market Share by Type (2018-2029)
4.2 Global Sofosbuvir Tablets Revenue by Type (2018-2029)
4.2.1 Global Sofosbuvir Tablets Revenue by Type (2018-2023)
4.2.2 Global Sofosbuvir Tablets Revenue by Type (2024-2029)
4.2.3 Global Sofosbuvir Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Sofosbuvir Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sofosbuvir Tablets Sales by Application (2018-2029)
5.1.1 Global Sofosbuvir Tablets Sales by Application (2018-2023)
5.1.2 Global Sofosbuvir Tablets Sales by Application (2024-2029)
5.1.3 Global Sofosbuvir Tablets Sales Market Share by Application (2018-2029)
5.2 Global Sofosbuvir Tablets Revenue by Application (2018-2029)
5.2.1 Global Sofosbuvir Tablets Revenue by Application (2018-2023)
5.2.2 Global Sofosbuvir Tablets Revenue by Application (2024-2029)
5.2.3 Global Sofosbuvir Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Sofosbuvir Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Gilead Sciences, Inc.
6.1.1 Gilead Sciences, Inc. Corporation Information
6.1.2 Gilead Sciences, Inc. Description and Business Overview
6.1.3 Gilead Sciences, Inc. Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Gilead Sciences, Inc. Sofosbuvir Tablets Product Portfolio
6.1.5 Gilead Sciences, Inc. Recent Developments/Updates
6.2 Shandong Shibo Jindu Pharmaceutical Co., Ltd.
6.2.1 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Sofosbuvir Tablets Product Portfolio
6.2.5 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 CTTQ
6.3.1 CTTQ Corporation Information
6.3.2 CTTQ Description and Business Overview
6.3.3 CTTQ Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CTTQ Sofosbuvir Tablets Product Portfolio
6.3.5 CTTQ Recent Developments/Updates
6.4 Sihuan Pharmaceutical Holdings Group Ltd.
6.4.1 Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
6.4.2 Sihuan Pharmaceutical Holdings Group Ltd. Description and Business Overview
6.4.3 Sihuan Pharmaceutical Holdings Group Ltd. Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sihuan Pharmaceutical Holdings Group Ltd. Sofosbuvir Tablets Product Portfolio
6.4.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments/Updates
6.5 Cspc Ouyi Pharmaceutical Co., Ltd.
6.5.1 Cspc Ouyi Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Cspc Ouyi Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Cspc Ouyi Pharmaceutical Co., Ltd. Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cspc Ouyi Pharmaceutical Co., Ltd. Sofosbuvir Tablets Product Portfolio
6.5.5 Cspc Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Beijing Kawin Technology Share-Holding Co., Ltd.
6.6.1 Beijing Kawin Technology Share-Holding Co., Ltd. Corporation Information
6.6.2 Beijing Kawin Technology Share-Holding Co., Ltd. Description and Business Overview
6.6.3 Beijing Kawin Technology Share-Holding Co., Ltd. Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beijing Kawin Technology Share-Holding Co., Ltd. Sofosbuvir Tablets Product Portfolio
6.6.5 Beijing Kawin Technology Share-Holding Co., Ltd. Recent Developments/Updates
6.7 DM Pharma
6.6.1 DM Pharma Corporation Information
6.6.2 DM Pharma Description and Business Overview
6.6.3 DM Pharma Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DM Pharma Sofosbuvir Tablets Product Portfolio
6.7.5 DM Pharma Recent Developments/Updates
6.8 Wellona Pharma
6.8.1 Wellona Pharma Corporation Information
6.8.2 Wellona Pharma Description and Business Overview
6.8.3 Wellona Pharma Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wellona Pharma Sofosbuvir Tablets Product Portfolio
6.8.5 Wellona Pharma Recent Developments/Updates
6.9 Mylan Laboratories
6.9.1 Mylan Laboratories Corporation Information
6.9.2 Mylan Laboratories Description and Business Overview
6.9.3 Mylan Laboratories Sofosbuvir Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mylan Laboratories Sofosbuvir Tablets Product Portfolio
6.9.5 Mylan Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sofosbuvir Tablets Industry Chain Analysis
7.2 Sofosbuvir Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sofosbuvir Tablets Production Mode & Process
7.4 Sofosbuvir Tablets Sales and Marketing
7.4.1 Sofosbuvir Tablets Sales Channels
7.4.2 Sofosbuvir Tablets Distributors
7.5 Sofosbuvir Tablets Customers
8 Sofosbuvir Tablets Market Dynamics
8.1 Sofosbuvir Tablets Industry Trends
8.2 Sofosbuvir Tablets Market Drivers
8.3 Sofosbuvir Tablets Market Challenges
8.4 Sofosbuvir Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
